The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
Our CEO Merith Basey will testify at Tuesday’s Senate Judiciary Committee hearing, “Prescribing Sunshine: How Competition & Transparency Lowers Prescription Drug Costs.” The hearing will focus on legislation to address the pharmaceutical industry’s abuse of the patent system — including through patent thickets, pay-for-delay deals, product hopping, and abuse of the citizen petition process.
News Nov 6, 2026CMS published the final rule for the Medicare Drug Price Negotiation program, codifying the program and effectively closed a loophole that pharmaceutical manufacturers could exploit to delay negotiation, as we highlighted in our comments.
News Oct 30, 2026The third round of Medicare drug price negotiations will end on November 1, with CMS expected to announce lower negotiated prices for the 15 selected drugs in the coming weeks.
News Oct 23, 2026The median annual net launch price of drugs jumped 35% from 2022 to 2025, reaching a “historically high level.” That’s according to a new report from the Institute for Clinical and Economic Review (ICER) this week, which found that the median net launch price for a new drug last year was nearly $257,000.
News Oct 16, 2026CBP just announced that it is delaying the implementation of its importation rule change by 90 days, until January 20, 2027, just one week before it was set to take effect.
News Oct 9, 2026On Monday, AstraZeneca revived one of its multiple lawsuits against Medicare negotiation, this time asking the Fourth Circuit to reverse a Maryland district court dismissal earlier this year.
News Oct 2, 2026The finalized GLOBE model is now projected to save just $440 million — a staggering 96% decrease from CMS’s original projection of $11.9 billion.
News Sep 25, 2026Newly released, heavily redacted Pfizer and Eli Lilly MFN agreements reveal concerning drug exclusions and terms while leaving key details about pricing and implementation unknown.
News Sep 18, 2026President Trump announced from the Oval Office that all 50 states have agreed to participate in the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) voluntary CMS model.
News Sep 11, 2026CMS Medicare director Chris Klomp will face back-to-back Senate confirmation hearings on Tuesday and Wednesday next week for the Deputy HHS Secretary role.
